Bristol-Myers Squibb Aktie News

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Announces Early Participation Results, Amendment and Early Settlement of Tender Offers.

Will the stock market finish the year higher or lower?

Shares of a delivery giant surged Friday on a new partnership, while a pharmaceutical firm came under pressure after it halted a trial of a key heart treatment.

Shares of Bristol Myers Squibb slumped Friday after the company scrapped a study testing a treatment for acute coronary syndrome.

Bristol Myers Squibb and Johnson & Johnson said on Friday they would stop a late-stage trial of their experimental blood clot drug in heart attack patients, after an independent review found the study was unlikely to meet its main goal.

PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Patients--Update on Phase 3 Librexia ACS Trial.

Bristol Myers Squibb has a high dividend yield, is very cheap, and may have better growth prospects than it might seem at first glance. Pfizer now has a 7% yield, and may have found a solution to its patent cliff issue.

NASHVILLE, Tenn.--(BUSINESS WIRE)--Sarah Cannon Research Institute (SCRI), one of the world's leading oncology research organizations conducting community-based clinical trials, and Bristol Myers Squibb (NYSE: BMY), a leading biopharmaceutical company, today announced an expanded strategic collaboration aimed at accelerating the development of innovative cancer therapies and increasing access t...